Published January 11, 2012, 01:13 PM
FDA says Johnson & Johnson erred in reporting insulin pump problems
Federal regulators have warned Johnson & Johnson that it could face fines and other sanctions for selling faulty insulin pumps and delaying disclosures of serious injuries to diabetics who used them. The Food and Drug Administration ordered J&J's Animas Corp. unit to promptly provide a plan to rectify its failure to report within 30 days cases where its device may have caused or contributed to death or serious injury.By: Linda A. Johnson, AP Business Writer
RSS Feeds